Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc."
Results 221 - 240
of 284
Sort by Relevance
|
Sort by Date
18 Mar 2011, 1:28 pm
Merrell Dow Pharmaceuticals, Inc. laid down the standard for admissibility of expert testimony. [read post]
18 Mar 2011, 10:04 am
Merrell Dow Pharm., Inc., 911 F.2d 941, 958-9 (3d Cir. 1990) Daubert v. [read post]
11 Mar 2011, 2:03 pm
In 1993 in Daubert v. [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23… [read post]
22 Feb 2011, 7:27 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in analyzing the expert presentations relating to the Rule 23 requirements, Plaintiffs contend that the Ninth Circuit found this to be no abuse of discretion, and that it did not matter because the district court judge was "guided by Daubert," concluded that the expert opinions were "based on valid principles," and were "sufficiently probative" of the Rule 23 requirements. [read post]
8 Feb 2011, 11:47 am
Merrill Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
30 Jan 2011, 5:29 pm
Merrell Dow Pharms., Inc., 43 F.3d 1311, 1315 (9th Cir.1995) (“ Daubert II ”). [read post]
27 Jan 2011, 5:14 pm
Citing the decision in Daubert v. [read post]
25 Jan 2011, 10:06 am
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993). [read post]
1 Dec 2010, 11:02 am
Merrell Dow Pharmaceuticals set the standard regarding the admissibility of expert witness testimony in federal court. [read post]
21 Nov 2010, 12:10 pm
Merrell Dow Pharmaceuticals, Inc., 959 F.2d 1349 (6th Cir.) [read post]
26 Oct 2010, 4:30 am
Merrell Dow Pharmaceuticals, decided by the Supreme Court in 1993. [read post]
24 Aug 2010, 11:34 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), in which the Court instructed district courts to function as gatekeepers and permit only reliable and relevant expert testimony to be presented to the jury. [read post]
4 Aug 2010, 7:57 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) established the test federal (and many state) judges currently use to determine the admissibility of expert testimony in trials and other proceedings. [read post]
17 Jul 2010, 10:13 pm
For example, an Arizona jury awarded a homeowner and his family more than $4 million for a case where the insurance carrier delayed remediating mold contamination (Hatley v. [read post]
8 Jul 2010, 3:30 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
4 Jul 2010, 4:16 pm
Merrell Dow Pharmaceuticals, Inc., 509 US 579 which, in federal courts, displaced the Frye general acceptance standard based upon the Federal Rules of Evidence. [read post]
23 Jun 2010, 3:35 pm
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 113 S. [read post]
27 May 2010, 3:40 pm
”Merrell Dow Pharmaceuticals, Inc. v. [read post]
6 May 2010, 4:12 pm
Metabolife International, Inc., 401 F.3d 1233, 1247 (11th Cir. 2005); Goebel v. [read post]
